Walk in or schedule your Pfizer COVID-19 vaccine! Monday through Thursday: 8 a.m. - 5 p.m. and Friday: 8 a.m. - noon >

Showing 1 - 2 of 2 Myasthenia Gravis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

Status: Enrolling

Investigator: Sheetal Shroff

Study Coordinator:

Phone:

The purpose of the MycarinGstudy is to demonstrate the clinical efficacy and to assess safety and tolerability of rozanolixizumab in patients with generalized myasthenia gravis (MG). NCT number: NCT03971422 ... Read more >

Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis

Status: Open Not Enrolling

Investigator: Ericka Greene

Study Coordinator:

Phone:

The primary purpose of this study is to evaluate the safety and efficacy of ravulizumab for the treatment of participants with generalized myasthenia gravis (gMG). [NCT03920293] ... Read more >